Tenaya Therapeutics: Funding, Investors & Team (Oct 2026)
A biotechnology company at the clinical stage is called Tenaya Therapeutics. Leading cardiovascular researchers from the David J. Gladstone Institutes and the University of Texas Southwestern Medical Center formed the company in 2016. Our bold objective as a biotechnology firm is to find, create, develop, and provide curative treatments that address the underlying causes of heart disease. Our goal is to alter the way that heart disease is treated, extending and improving the lives of millions of people and families who are coping with this crippling condition. We are developing a pipeline of disease-modifying treatments to target certain sub-populations of individuals with uncommon or widely prevalent forms of cardiac disease. These therapies were created using our product platforms and core internal capabilities.
Tenaya Therapeutics has raised $299M across 5 funding rounds on record, the most recent an undisclosed round of $60.0M announced in Dec 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Tenaya Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Tenaya Therapeutics Funding Rounds
Tenaya Therapeutics raised $106M in a Series C announced in Mar 2021.
1.7 years later, an undisclosed round of $75.0M was announced in Nov 2022.
1.3 years later, an undisclosed round of $50.0M was announced in Feb 2024.
1 years later, an undisclosed round of $8.0M was announced in Feb 2025.
10 months later, an undisclosed round of $60.0M was announced in Dec 2025.
Tenaya Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Tenaya Therapeutics Funding Compared to Other Biotechnology Startups
Tenaya Therapeutics' latest round of $60.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Tenaya Therapeutics in Biotechnology and San Francisco
Companies Similar to Tenaya Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Tenaya Therapeutics Funding FAQs
What does Tenaya Therapeutics do?
A biotechnology company at the clinical stage is called Tenaya Therapeutics. Leading cardiovascular researchers from the David J. Gladstone Institutes and the University of Texas Southwestern Medical Center formed the company in 2016. Our bold objective as a biotechnology firm is to find, create, develop, and provide curative treatments that address the underlying causes of heart disease. Our goal is to alter the way that heart disease is treated, extending and improving the lives of millions of people and families who are coping with this crippling condition. We are developing a pipeline of disease-modifying treatments to target certain sub-populations of individuals with uncommon or widely prevalent forms of cardiac disease. These therapies were created using our product platforms and core internal capabilities.
How much funding has Tenaya Therapeutics raised?
Tenaya Therapeutics has raised $299M across 5 rounds on record. The most recent is an undisclosed round of $60.0M announced in Dec 2025.
When did Tenaya Therapeutics last raise funding?
Tenaya Therapeutics' most recent funding round on record is an undisclosed round of $60.0M, announced in Dec 2025.
Who founded Tenaya Therapeutics?
FundedIQ lists Benoit Bruneau (Founder), Bruce Conklin (Founder), Eric Olson (Founder) at Tenaya Therapeutics.
Who is the CEO of Tenaya Therapeutics?
Faraz Ali is listed as CEO at Tenaya Therapeutics.
Where is Tenaya Therapeutics headquartered?
Tenaya Therapeutics is based in San Francisco, California, United States.
How many employees does Tenaya Therapeutics have?
Tenaya Therapeutics is in the 101-250 employee band.
How does Tenaya Therapeutics' funding compare to other Biotechnology startups?
Tenaya Therapeutics' latest round of $60.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Tenaya Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Tenaya Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.